C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/26/2006	US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
12/26/2006	US7153950 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders
12/26/2006	US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers
12/26/2006	US7153948 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
12/26/2006	US7153947 Ixodes salivary anticomplement protein
12/26/2006	US7153946 Molecular conjugates for use in treatment of cancer
12/26/2006	US7153945 Peptide, novel adsorbent, adsorption unit and adsorption method
12/26/2006	US7153944 High affinity integrin polypeptides and uses thereof
12/26/2006	US7153943 Derivatives of growth hormone and related proteins, and methods of use thereof
12/26/2006	US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy
12/26/2006	US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006	US7153937 Eukaryotic zcyto7 polypeptide; for proliferation and/or differentiation of cells; restoration of normal blood cell levels in chemotherapy patients
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006	US7153935 Tumor suppressor gene
12/26/2006	US7153934 T cell costimulatory polypeptides containing alternative domains
12/26/2006	US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
12/26/2006	US7153932 Immunotoxins comprising ribosome-inactivating proteins
12/26/2006	US7153931 Forms of membrane transport vector penetratin; a membrane translocation peptide carrier moiety of given amino acid sequence; use in the improved delivery of therapeutic agents into target cells
12/26/2006	US7153930 Peptide transport
12/26/2006	US7153836 Having 1-4 hydrophobic C 10-24 aliphatic, saturated or unsaturated hydrocarbon residue moieties covalently bound to a protein with a hedgehog N-terminal domain; includes auxiliary substances, detergents, stabilizers, matrix materials, suramin, heparin, anionic polysaccharides and/or sequestering agents
12/26/2006	US7153833 Therapeutic uses of SMR1 peptides
12/26/2006	US7153832 Compositions of active Wnt protein
12/26/2006	US7153831 Rabconnectin-3-binding protein
12/26/2006	US7153830 Administering factor XIII systemically optionally in conjunction with activated thrombin.
12/26/2006	US7153829 Preventing or reducing neurocognitive defects due to reperfusion injury and/or damage to the central nervous system, such as cerebral ischemia caused by various kinds of strokes, by administering a polypeptide inhibitor of plasma kallikrein, Ecallantide
12/26/2006	US7153828 Use of heregulin as a growth factor
12/26/2006	US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006	US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes
12/26/2006	US7153823 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
12/26/2006	US7153685 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression
12/26/2006	US7153672 Preparing a cDNA molecule by contacting an RNA molecule, in the presence of dNTPs, with a non-LTR retrotransposon protein or polypeptide having reverse transcriptase, producing a cDNA molecule complementary to the RNA molecule
12/26/2006	US7153670 Isolated nucleic acid molecule of nucleotides that encode full-length WF-HABP, Hyaluronan-binding protein family
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders
12/26/2006	US7153667 Discrete acyltransferases associated with type I polyketide synthases and methods of use
12/26/2006	US7153665 Using retroviral expression vector comprising immunoglobulin E and regulatory sequences to transfom cells and identify regulator of immunoglobulin E biosynthesis
12/26/2006	US7153664 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders
12/26/2006	US7153663 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006	US7153661 Artificial antibody polypeptides
12/26/2006	US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus
12/26/2006	US7153653 Regulation of gene expression; determining DNA methylation and relation to cell proliferative disorder
12/26/2006	US7153535 Protein sweetener
12/26/2006	US7153515 Method of preventing T cell-mediated responses by the use of the major histocompatibility complex class II analog protein (map protein) from Staphylococcus aureus
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/26/2006	US7153509 Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
12/26/2006	US7153508 Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
12/21/2006	WO2006135762A1 Identification of a folliculin-binding protein fnip1
12/21/2006	WO2006135738A2 Devices from prion-like proteins
12/21/2006	WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use
12/21/2006	WO2006135151A1 Novel environmental stress resistance transcription factor and method for enhancing environmental stress resistance of plants using the same
12/21/2006	WO2006135110A1 Sulfate ion transporter gene and use thereof
12/21/2006	WO2006134443A1 Dengue serotype 2 attenuated strain
12/21/2006	WO2006134433A1 Dengue serotype 1 attenuated strain
12/21/2006	WO2006134390A2 Method for diagnosing neurodegenerative disease
12/21/2006	WO2006134342A2 Mutants of human app and their use for the production of transgenic animals
12/21/2006	WO2006134340A2 Oxyntomodulin analogues and their effects on feeding behaviour
12/21/2006	WO2006134280A2 Mutated nucleotide sequences of the hepatitis c virus
12/21/2006	WO2006134185A1 Method for the diagnosis of alzheimer's disease
12/21/2006	WO2006134173A2 Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine
12/21/2006	WO2006133931A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening
12/21/2006	WO2006133911A2 Hepatitis c virus nucleic acid vaccine
12/21/2006	WO2006133853A1 Heterodimeric peptide compounds displaying ngf activity and their use to treat neurodegenerative disorders
12/21/2006	WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
12/21/2006	WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006	WO2006133553A1 Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins
12/21/2006	WO2006133508A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006	WO2006133486A1 CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTOR:Fc COMPLEXES AND USES THEREOF
12/21/2006	WO2006110182A3 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
12/21/2006	WO2006108686A3 Bnp agonists
12/21/2006	WO2006101441A3 Method for protein purification comprising heat incubation in acetic acidic solution
12/21/2006	WO2006100430A3 Polypeptides
12/21/2006	WO2006097732A3 Treatment of autoimmune and inflammatory diseases
12/21/2006	WO2006097336A3 A novel component of the wg/wnt signaling pathway
12/21/2006	WO2006088803A3 Polypeptides from staphylococcus aureus and methods of use
12/21/2006	WO2006085121A3 Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
12/21/2006	WO2006080032A3 Antifungal protein
12/21/2006	WO2006078733A3 Estrogen receptor structure
12/21/2006	WO2006074432A3 Adiponectin variants
12/21/2006	WO2006073827A3 Neutralizing epitope-based growth enhancing vaccine
12/21/2006	WO2006073447A3 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals
12/21/2006	WO2006071796A3 Pulmonary surfactant formulations
12/21/2006	WO2006059130A3 Manipulation of starch granule size and number (ii)
12/21/2006	WO2006014999A3 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
12/21/2006	WO2005121172A8 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/21/2006	WO2005116073A3 Pdx1 expressing endoderm
12/21/2006	WO2005110015A3 Cross-linkable glycoproteins and methods of making the same
12/21/2006	WO2005104810A3 Novel therapeutic targets in cancer
12/21/2006	WO2005099449A3 Animal model, cells, and treatment for malignant melanoma
12/21/2006	WO2005086794A3 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
12/21/2006	WO2005062967A3 Novel anti-il 13 antibodies and uses thereof
12/21/2006	WO2005027711A3 Capsid-modified adenovirus vectors and methods of using the same
12/21/2006	WO2005016127A3 Prion-specific peptide reagents
12/21/2006	WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	WO2004063332A3 Cancer related genes
12/21/2006	WO2004041172A3 Interferon antagonists useful for the treatment of interferon related diseases
12/21/2006	WO2004020578A3 Glycosylation modified il-20
12/21/2006	WO2003091409A3 Identification of compounds which stimulate bone formation using a cell-based screening assay targeting bmp signaling
12/21/2006	WO2003054144A3 Human ras interacting protein

1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 2916